Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
August 2021 CPRIT Funding
for faculty recruitments and high-impact, high-risk awards
to build clinical trial network infrastructure across Texas
for early clinical investigator awards
In August, the Cancer Prevention and Research Institute of Texas
(CPRIT) announced its 2021 funding. MD Anderson was awarded a total
of $12.75 million to support basic, clinical, translational and
prevention research effort. See how it breaks down.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
Meet our cancer researchers
MD Anderson faculty focus on a variety of research topics that contribute to our goal of ending cancer.
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program® was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.Learn more about the Moon Shots Program
Statins for TNBC
Peritoneal cancer study
What is Patient Mosaic™?
Program uses whole genome sequencing and genetic analysis to personalize cancer treatment